Vivo Infusion announced on June 20 that it has acquired Specialty Infusion for an undisclosed price. With this acquisition, Vivo Infusion will operate 55 ambulatory infusion centers across ten states.
Founded in 2018, Specialty Infusion provides ambulatory infusion and specialty pharmacy services at 14 ambulatory infusion centers in New York, Massachusetts and New Jersey.
Vivo Infusion is a provider of infusion and injection care for patients suffering from compromised immune systems, infectious diseases and other medical conditions. Vivo serves communities in Colorado, Florida, Ohio, Oklahoma, Pennsylvania, New Jersey and Texas with plans to expand to additional states. Private equity firm InTandem Capital Partners created Vivo Infusion by merging MPP Infusion Centers and ID Consultants in March 2022.
The Specialty Infusion acquisition marks Vivo Infusion’s second deal of 2023. In January, Vivo Infusion acquired CIVIC Infusion in Wilton, Connecticut for an undisclosed price.
